ArticleInternational health2017
Charting a path forward: policy analysis of China's evolved DRG-based hospital payment system.
Article in International health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The effects of diagnosis-related groups payment on hospital healthcare in China: a systematic review.BMC health services research · 2020Pooled it
- Trends and outcomes ofMicrobiology spectrum · 2026Article
- Article
- Association of DRG-based payment reform with inpatient costs and resource use among older adults: an interrupted time series study in a county-level referral hospital in China.Frontiers in public health · 2026Article
- Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective.PloS one · 2026Article
- Predicting 30-day readmission using DRG-based hospitalization data: a large real-world logistic regression model from a tertiary hospital.Frontiers in public health · 2026Article
- Can DRG payment under global budget with price adjustment curb the soaring healthcare costs? Insights from China's reform and its underlying mechanism.BMC public health · 2025Article
- Validation of the Patient Driven Payment Model (PDPM) in China.BMC health services research · 2025Article
- The effects of the diagnosis-intervention packet payment reform in China: evidence from Guangzhou.Frontiers in public health · 2025Article
- Analysis and optimization of inpatient cost structure for fracture patients under the implementation of the DRG policy.Frontiers in public health · 2025Article
- Exploring the cost implications of different treatment modalities for uterine fibroids under the DRG system.Frontiers in public health · 2025Article
- Impact analysis of DRG payment reform on hospitalization expenses and length of stay for lung cancer inpatients (2019-2023).Frontiers in health services · 2025Article
- Spatio-temporal evolution of financial sustainability in Chinese public hospitals: evidence from provincial panel data (2010-2022).Frontiers in public health · 2025Article
- Evaluation of the effect of DRG payment policy based on interrupted time series modeling: evidence from a tertiary hospital in Anhui Province.Health research policy and systems · 2024Article
- Surgical treatment of liver cancer and pancreatic cancer under the China Healthcare Security Diagnosis Related Groups payment system.World journal of clinical cases · 2024Article
- Exploring hot topics and evolutionary paths in the Diagnosis-Related Groups (DRGs) field: a comparative study using LDA modeling.BMC health services research · 2024Article
- A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis.Risk management and healthcare policy · 2024Article
- The influence of policy advocacy and education on medical staff's adaptation to diagnosis related groups payment reform in China: an analysis of the mediating effect of policy cognition.Frontiers in public health · 2024Article
- Evaluation of inpatient services of tertiary comprehensive hospitals based on DRG payment.Frontiers in public health · 2024Article
- Effects of a Diagnosis-Related Group Payment Reform on Length and Costs of Hospitalization in Sichuan, China: A Synthetic Control Study.Risk management and healthcare policy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: At present, the diagnosis-related groups-based prospective payment system (DRG-PPS) that has been implemented in China is merely a prototype called the simplified DRG-PPS, which is known as the 'ceiling price for a single disease'. Given that studies on the effects of a simplified DRG-PPS in China have usually been controversial, we aim to synthesize evidence examining whether DRGs can reduce medical costs and length of stay (LOS) in China. Methods: Data were searched from both Chinese [Wan Fang and China National Knowledge Infrastructure Database (CNKI)] and international databases (Web of Science and PubMed), as well as the official websites of Chinese health departments in the 2004-2016 period. Only studies with a design that included both experimental (with DRG-PPS implementation) and control groups (without DRG-PPS implementation) were included in the review. Results: The studies were based on inpatient samples from public hospitals distributed in 12 provinces of mainland China. Among them, 80.95% (17/21) revealed that hospitalization costs could be reduced significantly, and 50.00% (8/16) indicated that length of stay could be decreased significantly. In addition, the government reports showed the enormous differences in pricing standards and LOS in various provinces, even for the same disease. Conclusions: We conclude that the simplified DRGs are useful in controlling hospitalization costs, but they fail to reduce LOS. Much work remains to be done in China to improve the simplified DRG-PPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.